26 Mar March 26, 2018
March 26, 2018 HHS Defends 340B Regulation that Cuts Payments In court filings last week, HHS argued that its 28.5 percent 340B drug payment reductions in the outpatient payment rule “were justified by developments in the market” due to the program's over-expansion. Additionally, HHS stated that it already...